Amarin Corp Plcuk (AMRN) Amortization of Deferred Charges (2012 - 2020)
Amarin Corp Plc\Uk (AMRN) posted quarterly Amortization of Deferred Charges of $34000.0 for Q4 2020, down 90.61% year-over-year from $362000.0 in Q1 2020, and down 69.37% quarter-over-quarter from $111000.0 in Q3 2020.
Amarin Corp Plcuk (AMRN) Amortization of Deferred Charges (2012 - 2020) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Amortization of Deferred Charges for 9 consecutive years, with $34000.0 the latest figure, recorded in Q4 2020.
- In Q4 2020, Amortization of Deferred Charges fell 90.61% year-over-year to $34000.0; the TTM figure through Dec 2020 stood at $635000.0 (down 61.37% YoY), while the FY2020 annual figure was $635000.0, down 61.37% from the prior year.
- Amortization of Deferred Charges fell to $34000.0 in Q4 2020 per AMRN's latest filing, from $111000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $2.6 million in Q2 2016 and bottomed at $34000.0 in Q4 2020.
- Historically, Amortization of Deferred Charges has averaged $728850.0 across 5 years, with a median of $542000.0 in 2016.
- Annual changes were most pronounced in 2016 — Amortization of Deferred Charges soared 36.65% — and 2020, when it sank 90.61%.
- Amarin Corp Plc\Uk's Amortization of Deferred Charges stood at $537000.0 in 2016, then climbed by 10.99% to $596000.0 in 2017, then retreated by 16.78% to $496000.0 in 2018, then decreased by 27.02% to $362000.0 in 2019, then tumbled by 90.61% to $34000.0 in 2020.
- Business Quant data shows AMRN's Amortization of Deferred Charges at $34000.0 in Q4 2020, $111000.0 in Q3 2020, and $201000.0 in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Amarin Corp Plcuk | 5.86 Bn | 5.54 Bn | 14.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 34,000.00 |
| Dec 31, 2020 | 34,000.00 |
| Sep 30, 2020 | 111,000.00 |
| Sep 30, 2020 | 111,000.00 |
| Jun 30, 2020 | 201,000.00 |
| Jun 30, 2020 | 201,000.00 |
| Mar 31, 2020 | 289,000.00 |
| Mar 31, 2020 | 289,000.00 |
| Dec 31, 2019 | 362,000.00 |
| Dec 31, 2019 | 362,000.00 |
| Sep 30, 2019 | 404,000.00 |
| Sep 30, 2019 | 404,000.00 |
| Jun 30, 2019 | 432,000.00 |
| Jun 30, 2019 | 432,000.00 |
| Mar 31, 2019 | 446,000.00 |
| Mar 31, 2019 | 446,000.00 |
| Dec 31, 2018 | 496,000.00 |
| Dec 31, 2018 | 496,000.00 |
| Sep 30, 2018 | 547,000.00 |
| Sep 30, 2018 | 547,000.00 |